NOTCH3 and CADASIL: In addition, we report a heterozygous pathogenic gain of cysteine mutation in NOTCH3 (p.R578C) detected in 1 control and already reported in a Korean patient with clinical suspicious CADASIL, implying that the penetrance of NOTCH3 mutations is variable (Kim et al., 2014).